Meeting
2016 ASCO Annual Meeting
Phase IB study of pembrolizumab in combination with chemoradiotherapy (CRT) for locally-advanced squamous cell carcinoma of the head and neck (LA-SCCHN).
Authors
Steven Francis Powell
Sanford Health, Sioux Falls, SD
Steven Francis Powell , Mark Mutuota Gitau , William Charles Spanos , Ashley Wayne Jensen , Ryan Kenneth Nowak , Michele Lohr , Susan E Puumala , Christie Ellison , Lora Jane Black , Jonathan D. Cheng , Assuntina Gesualda Sacco , Ezra E.W. Cohen , John H. Lee
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Local-Regional Disease
Clinical Trial Registration Number
NCT02586207
Citation
J Clin Oncol 34, 2016 (suppl; abstr TPS6107)
DOI
10.1200/JCO.2016.34.15_suppl.TPS6107
Abstract #
TPS6107
Poster Bd #
426a
Abstract Disclosures
Similar Posters
Poster
2019 Gastrointestinal Cancers Symposium
Safety and efficacy of durvalumab following trimodality therapy for locally advanced esophageal and GEJ adenocarcinoma: Early efficacy results from Big Ten Cancer Research Consortium study.
First Author: Hirva Mamdani
Poster
2017 ASCO Annual Meeting
KEYNOTE-412: Pembrolizumab (pembro) in combination with chemoradiation versus chemoradiation alone in locally advanced head and neck squamous cell carcinoma (LA-HNSCC).
First Author: Jean-Pascal H. Machiels
Poster
2017 ASCO Annual Meeting
A randomized phase II study of chemoradiation and pembrolizumab for locally advanced cervical cancer.
First Author: Linda R. Duska
Poster
2024 ASCO Genitourinary Cancers Symposium
Preliminary efficacy and safety results from ReBirth: A phase II study of risk-based bladder-sparing therapy for MIBC.
First Author: Yijun Shen